Coffee is not classified as a carcinogen. The World Health Organization’s International Agency for Research on Cancer (IARC) reviewed more than 1,000 studies and concluded in 2016 that there is “inadequate evidence” that drinking coffee causes cancer, placing it in Group 3, meaning it is not classifiable as carcinogenic to humans. In fact, coffee appears to lower the risk of several types of cancer.
How Coffee’s Classification Changed
In 1991, IARC classified coffee as “possibly carcinogenic to humans” (Group 2B) based on limited evidence available at the time. That label stuck for 25 years. By 2016, the body of research had grown enormously, and a working group re-evaluated the evidence across both human and animal studies. The conclusion was clear enough to downgrade coffee to Group 3, effectively removing the cancer concern.
This reclassification also rippled through regulatory decisions. California’s Proposition 65, a law requiring cancer warnings on products containing known carcinogens, had been the subject of lawsuits demanding that coffee carry warning labels. The state’s Office of Environmental Health Hazard Assessment proposed a regulation clarifying that cancer warnings are not required for coffee, stating that “drinking coffee does not pose a significant cancer risk, despite the presence of chemicals created during the roasting and brewing process.” The regulation acknowledged that while roasting does produce listed chemicals, the overall evidence shows coffee doesn’t increase cancer risk and may reduce it.
Cancers Coffee May Protect Against
The World Cancer Research Fund says there is strong evidence that coffee reduces the risk of both liver cancer and endometrial (womb) cancer. Weaker but suggestive evidence also links coffee to lower risk of cancers of the mouth, throat, larynx, and certain skin cancers.
The liver cancer data is particularly striking. A large pooled analysis found that high coffee consumption was associated with a 56% reduction in liver cancer risk compared to not drinking coffee at all. Each additional cup per day was linked to roughly a 20% decrease. Women who drank more than three cups daily had a 54% lower risk, while the effect in men was more modest.
For endometrial cancer, the relationship follows a dose-response pattern. Compared to non-drinkers, women drinking one cup a day had a 5% lower risk, two cups brought a 10% reduction, and four cups a day was associated with a 20% reduction. Postmenopausal women saw an even larger benefit, with four cups linked to a 24% reduction.
There’s also evidence for colorectal cancer. People drinking four to five cups of caffeinated coffee a day had a 14% lower risk of colon cancer, and those drinking six or more cups had a 26% lower risk. A separate study funded by the World Cancer Research Fund found that people who had already been treated for bowel cancer and drank more than four cups daily had a lower risk of recurrence and lower risk of death after diagnosis.
Why Coffee Has Protective Effects
Coffee contains hundreds of biologically active compounds, and the most studied is a potent antioxidant called chlorogenic acid. This compound activates a key protective system inside cells: it triggers a protein that switches on a cascade of defensive genes. These genes produce enzymes that neutralize harmful molecules called free radicals, which can damage DNA and lead to cancer over time. In laboratory studies, when this protective pathway was blocked, the benefits of chlorogenic acid disappeared entirely, confirming it plays a central role.
Beyond antioxidant effects, coffee influences inflammation, insulin sensitivity, and bile acid metabolism, all of which are connected to cancer development. The liver cancer connection makes particular biological sense because the liver is where coffee compounds are most concentrated during metabolism.
Chemicals Produced During Roasting
The reason coffee ever raised cancer concerns is that roasting produces small amounts of chemicals that are, on their own, classified as carcinogens. Two main ones come up in this conversation: acrylamide and polycyclic aromatic hydrocarbons (PAHs).
Acrylamide forms when sugars and amino acids react at high temperatures. Roasted coffee contains an average of about 179 micrograms per kilogram, while instant coffee runs higher at around 358 micrograms per kilogram. For context, coffee substitutes (grain-based beverages) contain even more, averaging 818 micrograms per kilogram. Darker roasts actually contain less acrylamide than lighter roasts, as the compound breaks down with prolonged heat exposure.
PAHs tell the opposite story. Total PAH levels increase with roasting intensity. Light roasted coffees contained 333 to 740 micrograms per kilogram, medium roasts ranged from 510 to 1,120, and dark roasts reached as high as 3,000 micrograms per kilogram. These are measurable amounts, but the concentrations present in a brewed cup (after filtering through water and paper) are far lower than what’s found in the whole bean.
The critical point is that these chemicals exist in coffee alongside hundreds of protective compounds, and the net effect, based on more than 1,000 studies, is either neutral or beneficial. Isolated chemicals can be harmful, but the overall beverage is not.
Decaf vs. Regular Coffee
Both caffeinated and decaffeinated coffee show cancer-protective associations, which makes sense given that the key antioxidants survive the decaffeination process. In one large study, decaf drinkers consuming four to five cups daily had a 19% lower risk of colon cancer, a figure comparable to the 14% reduction seen with the same amount of caffeinated coffee. Decaf drinkers also showed a significant trend toward lower rectal cancer risk. This suggests caffeine itself isn’t the main protective agent. Rather, the chlorogenic acid and other compounds present in all types of coffee are doing the heavy lifting.
Temperature Matters More Than the Coffee
While coffee itself isn’t a carcinogen, the temperature you drink it at can be. In the same 2016 evaluation that cleared coffee, IARC classified drinking very hot beverages (above 65°C, or about 149°F) as “probably carcinogenic to humans” (Group 2A) for esophageal cancer. This applies to any beverage, not just coffee. The thermal damage to cells lining the esophagus, repeated over years, increases cancer risk. Most coffee served in homes and cafes is consumed well below this threshold, especially if you add milk or let it cool for a few minutes before drinking.